Back to search

University of South Florida

Substrate-Based Inhibitors of Peptidylglycine á-Amidating Monooxygenase (PAM) as Anti-Proliferative Drugs for Cancer

Abstract

dc:description

C-Terminal glycine-extended prohormones are enzymatically converted to á-amidated peptides, by peptidylglycine á-amidating monooxygenase (PAM). PAM is a bifunctional enzyme with two catalytic domains: peptidylglycine á-hydroxylating monooxygenase (PHM) and peptidylglycine peptidylglycineaminoglycolate lyase (PAL). PAM has a significant role in the proliferation of androgen-independent prostate cancer. Thus, the inhibition of PAM could halt cancer growth. Hippurate and hippurate analogs were used as lead compounds for developing inhibitors for PAM. The hippurate analogs exhibiting the highest affinity to PAM (lowest inhibition constant) did inhibit the growth of human androgen-independent prostate cancer DU 145 cells.

Degree

thesis:*
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Chemistry
Grantor
University of South Florida
Year dc:date
2003

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chew, Geoffrey H
Contributors dc:contributor
  • David Merkler, Ph.D.
  • Randy Larsen, Ph.D.
  • Gloria Ferreira, Ph.D.

Subjects

dc:subject × 7

Rights

Language dc:language
EN-US

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/1341

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Chew, Geoffrey H. Substrate-Based Inhibitors of Peptidylglycine á-Amidating Monooxygenase (PAM) as Anti-Proliferative Drugs for Cancer. Thesis thesis, University of South Florida, 2003. https://digitalcommons.usf.edu/etd/1341